Hasegawa, K.; Tamaki, M.; Yamaguchi, S.; Shimizu, I.; Kida, T.; Miyakami, S.; Tada, M.; Okinari, C.; Otsuka, M.; Minato, M.;
et al. Empagliflozin Prevents Cardiac Arrest-Induced Renal Injury Through BHB-Dependent Mitoribosome Maintenance. Int. J. Mol. Sci. 2026, 27, 6366.
https://doi.org/10.3390/ijms27146366
AMA Style
Hasegawa K, Tamaki M, Yamaguchi S, Shimizu I, Kida T, Miyakami S, Tada M, Okinari C, Otsuka M, Minato M,
et al. Empagliflozin Prevents Cardiac Arrest-Induced Renal Injury Through BHB-Dependent Mitoribosome Maintenance. International Journal of Molecular Sciences. 2026; 27(14):6366.
https://doi.org/10.3390/ijms27146366
Chicago/Turabian Style
Hasegawa, Kazuhiro, Masanori Tamaki, Sumiyo Yamaguchi, Ikuko Shimizu, Takahiro Kida, Shinji Miyakami, Miho Tada, Chihiro Okinari, Makoto Otsuka, Masanori Minato,
and et al. 2026. "Empagliflozin Prevents Cardiac Arrest-Induced Renal Injury Through BHB-Dependent Mitoribosome Maintenance" International Journal of Molecular Sciences 27, no. 14: 6366.
https://doi.org/10.3390/ijms27146366
APA Style
Hasegawa, K., Tamaki, M., Yamaguchi, S., Shimizu, I., Kida, T., Miyakami, S., Tada, M., Okinari, C., Otsuka, M., Minato, M., & Wakino, S.
(2026). Empagliflozin Prevents Cardiac Arrest-Induced Renal Injury Through BHB-Dependent Mitoribosome Maintenance. International Journal of Molecular Sciences, 27(14), 6366.
https://doi.org/10.3390/ijms27146366
